Abstract: An IV holder for securing an IV needle and Luer fitting assembly. The IV holder includes a frame defining an aperture with a first portion and a second portion, the first portion of the aperture further being covered by a transparent window for protecting and securing the IV needle insertion site. The second portion of the aperture is disposed to fit a cylindrical Luer fitting. The holder is adhesively applied to a patient's skin and situated so that the needle insertion site is under the window and the first portion of the aperture while the Luer fitting is disposed within the second portion of the aperture.

Abstract: A medicant composition is provided. The composition includes a film layer and a powder matrix layer. The powder matrix layer includes a medicant. The powder matrix layer is applied to the film layer by admixing particulate to form a powder matrix and by then applying the powder matrix to the film layer by any desired method. The composition of the powder matrix is varied to alter the dissolution rate of the medicant, the adhesion of the medicant composition, and other physical properties of the powder matrix. The powder matrix layer can be cured.

Abstract: A medicant composition is provided. The composition includes a film layer and a powder matrix layer. The powder matrix layer includes a medicant. The powder matrix layer is applied to the film layer by admixing particulate to form a powder matrix and by then applying the powder matrix to the film layer by any desired method. The composition of the powder matrix is varied to alter the dissolution rate of the medicant, the adhesion of the medicant composition, and other physical properties of the powder matrix. The powder matrix layer can be cured.

Abstract: An IV holder for securing an IV needle and Luer fitting assembly. The IV holder includes a frame defining an aperture with a first portion and a second portion, the first portion of the aperture further being covered by a transparent window for protecting and securing the IV needle insertion site. The second portion of the aperture is disposed to tit a cylindrical Luer fitting. The holder is adhesively applied to a patient's skin and situated so that the needle insertion site is under the window and the first portion of the aperture while the Luer fitting is disposed within the second portion of the aperture.

Abstract: Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use are disclosed.

Abstract: An IV holder for securing an IV needle and Luer fitting assembly. The IV holder includes a frame defining an aperture with a first portion and a second portion, the first portion of the aperture further being covered by a transparent window for protecting and securing the IV needle insertion site. The second portion of the aperture is disposed to fit a cylindrical Luer fitting. The holder is adhesively applied to a patient's skin and situated so that the needle insertion site is under the window and the first portion of the aperture while the Luer fitting is disposed within the second portion of the aperture.

Abstract: A system hydrates an individual prior to participation in a sporting event. The system comprises a container charged with a thirst inducing aqueous nutritional supplement gel composition and configured to dispense repeatedly a dose of said aqueous gel composition having a selected volume. The selected volume of the dose is in the range of 0.25 to 3.0 cc. The thirst inducing gel composition has a viscosity in the range of 3000 to 12,500; has a pH in the range of 2.0 to 2.8. The gel composition also includes 9% to 30% by weight of a flavoring; at least one acidulant selected from a group consisting of citric acid, ascorbic acid, malic acid, and tartaric acid; at least one sweetener; 0.03 to 0.09% by weight of piperines; and, 35% to 40% by weight water.

Abstract: A method to produce compositions with a standardized phytochemical content comprises growing marijuana in a controlled environment, harvesting live green leaves from the marijuana, processing the green leaves to produce a phytochemically standardized slurry, heating the slurry to produce a thin film, and cutting a film into pieces each sized to contain a selected dosage of the phytochemical.

Abstract: A method to reduce sexual discomfort for a woman during sexual intercourse vaginally introduces a lubricant composition comprising carrageenan comprising 0 to 92% by weight iota carrageenan, 10% to 100% by weight lambda carrageenan, and, 0 to 18% by weight kappa carrageenan; water such that the ratio of carrageenan to water is in the range of 1:10 to 1:50; at least one prebiotic; and, a natural humectant with a peak tackiness force of less than 50 g and a work of adhesion of less than 0.500 GS.

Abstract: A creamer composition is provided for a beverage, along with a method to deliver beneficial probiotic microorganisms to an individual using a foaming creamer applied to the surface of a hot beverage via an unpressurized container.

Abstract: A medicant composition is provided. The composition includes a film layer and a powder matrix layer. The powder matrix layer includes a medicant. The powder matrix layer is applied to the film layer by admixing particulate to form a powder matrix and by then applying the powder matrix to the film layer by any desired method. The composition of the powder matrix is varied to alter the dissolution rate of the medicant, the adhesion of the medicant composition, and other physical properties of the powder matrix. The powder matrix layer can be cured.

Abstract: A method is provided to sweeten a food product to minimize the glycemic load of the food product, to introduce natural fiber into the food product, to produce a desired sweetness profile, and to reduce the likelihood that the food product when ingested causes gastrointestinal distress.

Abstract: A personal lubricant paired with an odorant release device.

Abstract: A natural prebiotic syrup concentrate with levels of inulin greater than 30% by weight.

Abstract: A method is provided to sweeten a food product to minimize the glycemic index of the food product, to introduce natural fiber into the food product, to produce a desired sweetness profile, and to reduce the likelihood that the food product when ingested functions as a laxative.

Abstract: A method to treat nasal tissue reduces the ability of a virus to infect a human being. The method comprises the steps of providing a liquid composition comprising water, a humectant, a foam builder, 0.01% to 9% by weight of a surfactant, and a minor effective quantity of thickener to produce a coating on the nasal tissue after the liquid composition is applied to the nasal tissue as a foam; applying the liquid composition to the nasal tissue as a foam; and, allowing bubbles in the foam to dissipate so that a coating forms on the nasal tissue.

Abstract: A process is provided to improve the insulin sensitivity and glucose tolerance of an individual's metabolism. The process includes providing at a first location at least one polyol in an aqueous solution. A minor effective amount of a water soluble mineral composition comprising chromium picolinate is admixed with the aqueous solution to produce an aqueous polyol-chromium composition. The composition is dried and processed to produce solid chromium-infused polyol particles. The particles are packaged and transported to a second location. A selected quantity of the chromium-infused polyol particles are used to produce a food product selected from a group consisting of a liquid food including a liquid and at least fifty percent solids by weight, and a solid food composition. The food products produced with the mineral-infused polyol particles are packaged. The packaged food products are sold to the individual. The individual ingests the food product containing the mineral-infused polyol.

Abstract: A medicant composition is provided. The composition includes a film layer and a powder matrix layer. The powder matrix layer includes a medicant. The powder matrix layer is applied to the film layer by admixing particulate to form a powder matrix and by then applying the powder matrix to the film layer by any desired method. The composition of the powder matrix is varied to alter the dissolution rate of the medicant, the adhesion of the medicant composition, and other physical properties of the powder matrix. The powder matrix layer can be cured.

Abstract: Edible thin films and methods of making same are provided. The edible thin films provide a variety of different products that can vary in flavor, color, shape, and mouthfeel.

Abstract: A viscous gel for delivering minor effective homeopathic amount of zinc or another metal to the nasal membrane.